




Searching News Database: autologous vaccine
HSMN NewsFeed - 8 Sep 2017
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
HSMN NewsFeed - 19 Oct 2015
AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer
AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer